Park Ha Biological Technology (BYAH) Liabilities and Shareholders Equity (2023 - 2026)

Park Ha Biological Technology (BYAH) has reported Liabilities and Shareholders Equity for 4 consecutive years, with $7.5 million the latest figure, recorded in Q2 2026.

• Quarterly Liabilities and Shareholders Equity rose 27.92% year-over-year to $7.5 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $22.3 million (changed N/A YoY) and the FY2025 annual result came in at $6.0 million, up 93.06% from the prior year.
• Liabilities and Shareholders Equity improved to $7.5 million in Q2 2026 per BYAH's latest filing, from $6.0 million in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for BYAH reached as high as $7.5 million in Q2 2026 and fell as low as $2.3 million in Q4 2023.
• A 4-year average of $4.9 million and a median of $5.8 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2025 — Liabilities and Shareholders Equity soared 93.06% — and 2026, when it gained 27.92%.
• Year by year, Liabilities and Shareholders Equity stood at $2.3 million in 2023, then jumped by 36.14% to $3.1 million in 2024, then surged by 93.06% to $6.0 million in 2025, then advanced by 25.34% to $7.5 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $7.5 million, $6.0 million, and $5.8 million for Q2 2026, Q4 2025, and Q2 2025 respectively.